Evolution of the Average Target: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Evolution of the Target Price: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Changes in Analyst Recommendations: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

5c0537b85cb6e0e7.b8mkijV6ZuEAWE5_mea8g1yvxTW9WW37C_JvMa2G_Sc.FfjP2AYpDphoHHYvzNaItxrBmlKQLyy8b5klRpT2mHM48f7CdjYjji0fIQ~abd2cecc41849ddef90b7d9a7309f3e5

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+14.84%
+5.49%
+6.6%
+7.19%
+7.52%
+5.92%
+29.21%
-7.25%
+6.44%
Average +8.44%
Weighted average by Cap. +9.43%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.32
Average target price
-

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. 600329 Stock
  4. Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited